Varbo, Anette

Triglycerides and cardiovascular disease

Nordestgaard, B. G., & Varbo, A. (2014) · The Lancet

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 1,419

Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease

Varbo, A., Benn, M., Tybjærg-Hansen, A., Jørgensen, A. B., Frikke-Schmidt, R., & Nordestgaard, B. G. (2013) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology

Cited by 1,115

Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies

Madsen, C. M., Varbo, A., & Nordestgaard, B. G. (2017) · European Heart Journal

Lipoproteins and Cardiovascular HealthParaoxonase enzyme and polymorphisms

Cited by 715

Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation

Varbo, A., Benn, M., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2013) · Circulation

Lipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular Diseases

Cited by 692

Remnant cholesterol as a cause of ischemic heart disease: Evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment

Varbo, A., Benn, M., & Nordestgaard, B. G. (2014) · Pharmacology & Therapeutics

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 251

Increased remnant cholesterol explains part of residual risk of all-cause mortality in 5414 patients with ischemic heart disease

Jepsen, A.-M. K., Langsted, A., Varbo, A., Bang, L. E., Kamstrup, P. R., & Nordestgaard, B. G. (2016) · Clinical Chemistry

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 218

Extreme nonfasting remnant cholesterol vs extreme LDL cholesterol as contributors to cardiovascular disease and all-cause mortality in 90000 individuals from the general population

Varbo, A., Freiberg, J. J., & Nordestgaard, B. G. (2015) · Clinical Chemistry

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 209

Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial

McGowan, B. M., Bruun, J. M., Capehorn, M., Pedersen, S. D., Pietiläinen, K. H., Muniraju, H. A. K., Quiroga, M., Varbo, A., & Lau, D. C. W. (2024) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 176

VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins

Balling, M., Afzal, S., Varbo, A., Langsted, A., Davey Smith, G., & Nordestgaard, B. G. (2020) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 175

Low nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization study

Thomsen, M., Varbo, A., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2014) · Clinical Chemistry

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 171

Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population

Varbo, A., & Nordestgaard, B. G. (2019) · Annals of Neurology

Lipoproteins and Cardiovascular HealthAcute Ischemic Stroke Management

Cited by 145

Remnant lipoproteins

Varbo, A., & Nordestgaard, B. G. (2017) · Current Opinion in Lipidology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 135

Remnant cholesterol and myocardial infarction in normal weight, overweight, and obese individuals from the copenhagen general population study

Varbo, A., Freiberg, J. J., & Nordestgaard, B. G. (2018) · Clinical Chemistry

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 133

Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population

Varbo, A., Nordestgaard, B. G., Tybjærg‐Hansen, A., Schnohr, P., Jensen, G. B., & Benn, M. (2011) · Annals of Neurology

Lipoproteins and Cardiovascular HealthAcute Ischemic Stroke Management

Cited by 122

Low-grade inflammation in the association between mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis: a study of more than 115000 individuals from the general population

Hansen, S. E. J., Madsen, C. M., Varbo, A., & Nordestgaard, B. G. (2019) · Clinical Chemistry

Pancreatitis Pathology and TreatmentPancreatic and Hepatic Oncology Research

Cited by 121

Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP Program

Perreault, L., Davies, M., Frias, J. P., Laursen, P. N., Lingvay, I., Machineni, S., Varbo, A., Wilding, J. P. H., Wallenstein, S. O. R., & le Roux, C. W. (2022) · Diabetes Care

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 87

Nonfasting Triglycerides, Low-Density Lipoprotein Cholesterol, and Heart Failure Risk: Two Cohort Studies of 113 554 Individuals

Varbo, A., & Nordestgaard, B. G. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology

Lipoproteins and Cardiovascular HealthHeart Failure Treatment and Management

Cited by 83

Hypertriglyceridemia-Associated Pancreatitis: New Concepts and Potential Mechanisms

Hansen, S. E. J., Varbo, A., Nordestgaard, B. G., & Langsted, A. (2023) · Clinical Chemistry

Pancreatitis Pathology and TreatmentLipid metabolism and disorders

Cited by 51

Unmet need for primary prevention in individuals with hypertriglyceridaemia not eligible for statin therapy according to European Society of Cardiology/European Atherosclerosis Society guidelines: a contemporary population-based study

Madsen, C. M., Varbo, A., & Nordestgaard, B. G. (2018) · European Heart Journal

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 47